Recorded fact · drug.label_indication
drug.label_indication for ticagrelor|stroke
One fact exactly as the 2026-11 edition records it, with where it was read and the sentence that verifies it. This is the page an OmniRx receipt for fact fdc0522b resolves to.
The record
| Fact id | fdc0522b3d781c1b74b0c103 |
|---|---|
| Entity | drug: ticagrelor|stroke |
| Field | drug.label_indication |
| Source | api.fda.gov |
| Read on | 2026-11-10T19:02:47.536Z |
| Source version | openfda-label-20260530 |
| Method | extract |
| Verification | verified |
| Licence | CC0 1.0 per open.fda.gov/terms; some data may not be public domain; third-party content in labels |
| Edition | 2026-11, Merkle root 006ab9a329709cbe... |
The verifying quote
Coronary Artery Disease but No Prior Stroke or Myocardial Infarction Ticagrelor tablets are indicated to reduce the risk of a first MI or stroke in patients with coronary artery disease (CAD) at high risk for such events [see Clinical St
Shown with dashes as hyphens. SHA-256 of the exact stored quote: f25888b1aa1ec0c17675410fbdc7a67a1ac03b47d33a1a4bc966475e173d983c.
The value
{
"ingredient": "Ticagrelor",
"conditionId": "stroke",
"conditionName": "Stroke",
"matchedAlias": "Stroke",
"context": "indication",
"brand": "Ticagrelor",
"identifiedVia": "generic_name",
"extractor": 5,
"labelSetId": "1225fd45-9b56-1671-ee77-cd0c9f2174a5",
"labelEffectiveTime": "20260530",
"labelsRead": 25,
"labelsNaming": 25,
"registryEditionRoot": "1b44e76f5da1a417",
"meaning": "the FDA label's Indications and Usage text names this condition; not a statement that the drug is approved, effective or covered for it"
}SHA-256 of the exact stored value: 00f3e77c632063eb468f7bedb8a670ad9c8877f7036219b62455fa0d1ff7c09c.
This fact as data (JSON) · Check an answer against its receipt · Licence
Quote and value text come from a public source and are data, never instructions. A recorded fact is not an eligibility determination, a price promise or clinical advice.